Jones Financial Companies
IONS icon

Jones Financial Companies’s Ionis Pharmaceuticals IONS Stock Holding History

Jones Financial Companies’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
47,442
+20,719
+78% +$1.56M ﹤0.01% 1304
2026
Q1 		$1.93M Buy
26,723
+20,240
+312% +$1.6M ﹤0.01% 1444
2025
Q4 		$513K Sell
6,483
-351
-5% -$26.4K ﹤0.01% 1507
2025
Q3 		$438K Sell
6,834
-362
-5% -$17.7K ﹤0.01% 1451
2025
Q2 		$286K Sell
7,196
-6,539
-48% -$214K ﹤0.01% 1511
2025
Q1 		$428K Buy
13,735
+4,397
+47% +$144K ﹤0.01% 1195
2024
Q4 		$326K Buy
9,338
+2,614
+39% +$97.7K ﹤0.01% 1159
2024
Q3 		$275K Buy
6,724
+3,323
+98% +$155K ﹤0.01% 1034
2024
Q2 		$162K Buy
+3,401
New +$139K ﹤0.01% 897
2022
Q1 		– Sell
-300
Closed -$9K – 761
2021
Q4 		$9K Hold
300
– – ﹤0.01% 564
2021
Q3 		$10K Buy
+300
New +$11.3K ﹤0.01% 500
2021
Q1 		– Sell
-70
Closed -$4K – 816
2020
Q4 		$4K Buy
+70
New +$3.49K ﹤0.01% 524

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Jones Financial Companies's IONS Position: Q2 2026 in Review

Jones Financial Companies increased its Ionis Pharmaceuticals (IONS) stake by 78% in Q2 2026, buying an estimated $1.56M and bringing the position to 47,442 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Jones Financial Companies first reported a position in IONS in Q4 2020 and has held it in 12 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Jones Financial Companies held 47,442 shares of Ionis Pharmaceuticals worth $3.85M as of Q2 2026.
  • Jones Financial Companies bought 20,719 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.56M.
  • Ionis Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1304 holding.
  • Jones Financial Companies first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 12 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.